P. Slivka

发表

Solubilized extracellular matrix from brain and urinary bladder elicits distinct functional and phenotypic responses in macrophages.

C. Dearth, S. Badylak, F. Meng, 2015, Biomaterials.

Small Molecule and Pooled CRISPR Screens Investigating IL17 Signaling Identify BRD2 as a Novel Contributor to Keratinocyte Inflammatory Responses.

D. Donnelly-roberts, Charles Lu, Namjin Chung, 2019, ACS Chemical Biology.

The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation

R. Fischer, Svenja Hester, A. Irvine, 2020, Cell Metabolism.

Evidence that opioids may have toll-like receptor 4 and MD-2 effects

S. Maier, L. Leinwand, L. Watkins, 2010, Brain, Behavior, and Immunity.

Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal site

Justin D Dietrich, A. Petros, P. Richardson, 2022, Scientific Reports.

Dual Blockade of Interleukin-1β and Interleukin-17A Reduces Murine Arthritis Pathogenesis but Also Leads to Spontaneous Skin Infections in Nonhuman Primates

M. Ruzek, P. Slivka, C. Cuff, 2018, The Journal of Pharmacology and Experimental Therapeutics.

A Constrained Peptide That Targets the TLR4/MD2 Interaction & Investigating the Mechanism of Ultra-stability in Bacterial Chemosensory Arrays

P. Slivka, 2012 .

An MD2 Hot‐Spot‐Mimicking Peptide that Suppresses TLR4‐Mediated Inflammatory Response in vitro and in vivo

L. Watkins, H. Yin, M. Hutchinson, 2011, Chembiochem : a European journal of chemical biology.

Peptide probes for protein transmembrane domains.

H. Yin, Gregory A. Caputo, P. Slivka, 2008, ACS chemical biology.

Effects of biologic scaffolds on human stem cells and implications for CNS tissue engineering.

S. Badylak, Peter M. Crapo, P. Slivka, 2014, Tissue engineering. Part A.

Fractionation of an ECM hydrogel into structural and soluble components reveals distinctive roles in regulating macrophage behavior.

C. Medberry, C. Dearth, S. Badylak, 2014, Biomaterials science.

Inhibition of COX1/2 alters the host response and reduces ECM scaffold mediated constructive tissue remodeling in a rodent model of skeletal muscle injury.

C. Dearth, S. Badylak, P. Slivka, 2016, Acta biomaterialia.

Defining a key receptor-CheA kinase contact and elucidating its function in the membrane-bound bacterial chemosensory array: a disulfide mapping and TAM-IDS Study.

Kene N. Piasta, B. Crane, J. Falke, 2013, Biochemistry.

Isolated bacterial chemosensory array possesses quasi- and ultrastable components: functional links between array stability, cooperativity, and order.

J. Falke, P. Slivka, 2012, Biochemistry.

Design, synthesis, and evaluation of biotinylated opioid derivatives as novel probes to study opioid pharmacology.

H. Yin, P. Slivka, T. Zhao, 2008, Bioconjugate chemistry.

ACT1 is required for murine IL-23-induced psoriasiform inflammation potentially independent of E3 ligase activity.

A. Lipovsky, S. Gauld, P. Slivka, 2021, The Journal of investigative dermatology.

Evidence that opioids may have toll-like receptor 4 and MD-2 effects

S. Maier, L. Leinwand, L. Watkins, 2010, Brain, Behavior, and Immunity.

A Peptide Antagonist of the TLR4–MD2 Interaction

L. Watkins, D. Sammond, H. Yin, 2009, Chembiochem : a European journal of chemical biology.

Importance of PLD2 in an IL‐23 driven psoriasiform dermatitis model and potential link to human psoriasis

Kathleen M. Smith, A. Lipovsky, P. Honore, 2023, The Journal of dermatology.